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(BNP)Abstract Purpose: The aims of our study are twofold: ﬁrst, to retrospectively identify the demo-
graphic characteristics and outcomes in cardiac surgery for adult congenital heart disease (ACHD);
second, to explore whether certain preoperative examinations are useful for assessing the risk of per-
ioperative mortality and morbidity.
Methods: Ninety-two ACHD patients who underwent cardiac surgery from 2009 to 2011 were
enrolled in the study. The subjects were classiﬁed into three groups based on the complexity of
the ACHD. We retrospectively collected data on demographics, operations, and postoperative
courses. We also collected the results of examinations performed in the three months leading up
to the cardiac surgery, including exercise tolerance testing and measurement of brain natriuretic
peptide (BNP).
Results: The 30-day mortality was 3.3%. A remarkable discrepancy was found between subjective
assessment and the severity of exercise intolerance by exercise tolerance testing. The NYHA class
was 1 or 2 in all but one of 13 patients with moderate-severe exercise intolerance and a high mor-
tality/major complication rate (53.8%). Patients with BNP = 100 pg/ml had a signiﬁcantly higher
mortality/major complication rate than patients with BNP < 100 (34.8% vs. 11.5%, p< 0.05),
but the sensitivity (53.3%) and positive predictive value (34.8%) were not high enough in them-
selves to identify patients at high risk of poor outcome., Tokyo
204 S. Kurokawa et al.Conclusion: Cardiac surgery could be safely performed in most ACHD cases. Exercise tolerance
testing can be useful in identifying patients at high risk of mortality or major complications.
BNP can be valuable in predicting poor outcomes after cardiac surgery.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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The population of patients with adult congenital heart disease
(ACHD) in Japan has skyrocketed over the last four decades
[1]. The number of ACHD patients surpassed the number of
pediatric CHD patients more than a decade ago, in 1997,
and today it surpasses 400,000 [1]. The distribution of ACHD
complexity has also dramatically changed over the same period
[1]. A Task Force of the American College of Cardiology
(ACC) categorized ACHD in three types, simple, moderate,
or complex [2]. Nowadays, cases with moderate to complex
ACHD make up one-third of all ACHD cases in Japan [1].
The same trends in the number of ACHD patients and
distribution of ACHD complexity are taking place in other
developed countries, as well [3–7]. For these reasons, anesthe-
siologists will be expected to provide anesthetic management
for a growing number of ACHD patients, especially patients
with moderate to complex CHD, who undergo cardiac sur-
gery, non-cardiac surgery, and delivery.
Meanwhile, care facilities for ACHD in Japan are still far
from ideally established. A nationwide survey revealed that
half of Japan’s training hospitals for board-certiﬁed cardiolo-
gists perform cardiac surgery, but only on small numbers of
patients [8]. The hospitals that performed the surgery generally
do so on less than 10 patients per year, and only 6 of them
nationwide have conducted more than 20 cardiac surgeries
per year [8]. This naturally limits the opportunities for training
in the ﬁeld for anesthesiologists. As a ﬁrst step to provide bet-
ter training, we should recognize the demographic characteris-
tics and outcomes of cardiac surgery for ACHD and gather
sufﬁcient knowledge on risk assessment for perioperative mor-
tality and morbidity. Our hospital has conducted an average of
30–40 cardiac surgeries per year, which makes it one of Japan’s
most-experienced hospitals in cardiac surgery for ACHD. As
such, knowledge of the demographic characteristics and out-
comes of cardiac surgery for ACHD at our hospital may be
useful for recognizing the same characteristics and outcomes
on a larger scale, for all of Japan or other developed countries.
The aims of this study are twofold; ﬁrst, to retrospectively
identify the demographic characteristics and outcomes in car-
diac surgery for ACHD performed at our hospital over the
three-year period; second, to explore whether certain preoper-
ative examinations are useful for assessing the risk of perioper-
ative mortality and morbidity.2. Methods
2.1. Patients
The study subjects were consecutive CHD patients who under-
went cardiac surgery under cardiopulmonary bypass (CPB) at
the age of 15 years or older at TokyoWomen’sMedical Univer-
sity Hospital over the period from January 1, 2009 to December
31, 2011. Patients undergoing aortic valve replacement forbicuspid aortic valve lesion were excluded from this study.
The patients were classiﬁed into three groups based on the com-
plexity of the CHD according to the deﬁnition established by
the ACC Task Force. This study was approved by the institu-
tional ethics committee with a waiver of the requirement to
obtain written informed consent from patients older than
20 years old and from the parents of younger patients.
2.2. Data collection
Medical charts, anesthetic records, and operative records were
retrospectively reviewed. Data on demographics (age, gender,
height, body weight, diagnosis, history of previous operations,
history of previous sternotomies, type of surgery, and type of
procedure), preoperative status (New York Heart Association
[NYHA] class and American Society of Anesthesiologists
physical status [ASA-PS]), operation (operation time, CPB
time, aortic cross-clamp [Ao-clamp] time, and the amount of
bleeding), and postoperative course (postoperative ventilation
time, length of ICU stay, length of hospitalization, mortality,
and morbidity) were collected. Morbidity consists of major
and minor complications. The major complications consist of
mechanical ventilatory support for longer than 7 days,
mechanical circulatory support, lethal ventricular arrhythmia,
bleeding requiring surgical hemostasis, cardiac tamponade
requiring drainage, permanent neurological deﬁcits, and heart
blocks requiring permanent pacemaker implantation. Minor
complications included temporal neurological deﬁcits, atrial
arrhythmia, pleural effusion, and pneumothorax.
2.3. Preoperative examinations
The results of the following examinations were collected if the
examinations were performed in the three months leading up
to cardiac surgery: exercise tolerance testing (cardiopulmonary
exercise testing [CPET] and 6-minute walk test [6MWT]), myo-
cardial perfusion imaging (MPI), and measurement of brain
natriuretic peptide (BNP), hemoglobin (Hb), and glomerular
ﬁltration rate (GFR).
2.4. Statistics
Data are shown as means plus-minus standard deviations or
medians with ranges (minimum to maximum). The chi-square
test and Mann–Whitney U test were used for comparisons
between two groups and one-way ANOVA was used for com-
parisons among three groups. A p value of less than 0.05 was
considered as statistical signiﬁcance.
3. Results
Ninety-two cases underwent cardiac surgery for ACHD during
the study period: 31 simple cases, 33 moderate cases, and 28
complex cases. Table 1 summarizes the demographic data of
Table 1 Complexity of CHD and type of surgery.
Simple Moderate Complex Total
No. of patients 31 33 28 92
Age (years) 40.6 ± 15.3 42.0 ± 18.1 24.8 ± 5.1a 36.3 ± 16.1
Body weight (kg) 57.9 ± 11.3 59.2 ± 14.4 55.2 ± 11.5 57.6 ± 12.5
Gender (male:female) 14:17 21:12 15:13 50:42
Correction 29 21 2 52 (56.5%)
Reoperation 2 12 25 39 (42.4%)
Palliation 0 0 1 1 (1.1%)
Data on age and body weight are shown as mean ± standard deviation.
a p< 0.05, vs. simple or moderate.
Figure 1 Distribution of age at surgery. Age at the time of
surgery peaked in the patients’ twenties. Most of the younger
patients had moderate to severe CHD requiring reoperations
following corrective surgery. Most of the elderly patients under-
went corrections for simple lesions like ASD.
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niﬁcantly younger than the patients in the other groups. Body
weight and gender were similar among the three groups.
3.1. Data on demographics
Age at the time of surgery was 36.3 ± 16.1 years on average
and a median of 31 years (Table 1). Age distribution peaked
in the patients’ twenties (Fig. 1). Forty-two (45.7%) patients
had a history of one or more previous operations and 3
patients had received as many as four previous operations,
the maximum number received. Forty-one (44.6%) patients
had a history of one or more previous sternotomies and 2
patients had received three sternotomies, the maximumTable 2 Type of procedure.
References n L–R shunt lesion (%)
TWMU This study 92 46.7
Europe [9] 2012 42.8
Netherlands [11] 830 26.5
USA [10] 719 5.2
UK [4] 474 15.0number received. Thirty-nine of the surgeries were reopera-
tions, 52 were corrective surgeries, and 1 was a bidirectional
Glenn operation for palliation (Table 1). Correction for left-
to-right (L–R) shunt was the most frequent procedure,
accounting for roughly half of the cases (Table 2). The next
most frequent, in descending order, were valve operations,
Fontan revisions, and operations for right ventricular outﬂow
tract (RVOT) lesions (Table 2).
3.2. Preoperative status
No preoperative NYHA class was identiﬁed in the patients’
medical charts in 11 cases. Nine out of 81 cases (11.1%) were
classiﬁed as NYHA class 3 or greater. Most of the cases
(69.6%) were classiﬁed as ASA-PS 3.
3.3. Amount of bleeding
Bleeding was signiﬁcantly greater in the complex group than in
the simple group or moderate group (969 ± 770 ml in the
complex group vs. 324 ± 198 ml and 578 ± 543 ml in the
simple group and moderate group, respectively, p< 0.05).
Patients with a previous history of one or more median stern-
otomies also had signiﬁcantly greater bleeding than cases with
no previous history of median sternotomy (826 ± 590 ml and
1183 ± 1082 ml in cases with one previous sternotomy and
cases with two or more previous sternotomies, respectively,
vs. 358 ± 230 ml in cases with no previous sternotomy,
p< 0.05).
3.4. CPB time, Ao-clamp time, and operation time
CPB time was signiﬁcantly longer in complex CHD than in
simple CHD (Table 3). Fifteen cases were excluded from the
analysis on Ao-clamp time because they received no Ao-
clamps. The Ao-clamp time was signiﬁcantly longer in both
moderate and complex CHD than in simple CHD (Table 3).Valve operation (%) RVOTR (%) Fontan revision (%)
22.8 7.6 14.1
3.3 11.7 2.0
23.8 12.6 2.4
8.2 19.1 5.1
 42.0 1.0
Table 3 CPB time, Ao-clamp time, and operation time.
Simple Moderate Complex
Operation (min) 280.5 (140–420) 342 (222–696)b 612 (299–1392)a
CPB time (min) 85.5 (43–151) 140 (50–461) 193 (56–1028)b
Ao-clamp (min) 37 (20–106) 88 (37–312)b 131 (53–194)b
Data on times are shown as medians and ranges.
a p< 0.05, vs. simple or moderate.
b p< 0.05, vs. simple.
Table 4 Duration of postoperative ventilation, length of ICU
stay, and length of hospitalization.
Simple Moderate Complex
Ventilation (h) 4 (1–17) 6 (1–872) 18 (3–338)
ICU stay (days) 2 (1–8) 4 (1–51) 8 (1–23)a
Hospitalization (days) 19 (12–64) 22 (16–230) 38.5 (8–87)a
Data on durations are shown as medians and ranges.
a p< 0.05, vs. simple.
Figure 2 Relationship between NYHA class and results of
exercise tolerance testing. An obvious discrepancy was observed
between severity in exercise tolerance testing and NYHA class in
our series. Even asymptomatic or mild symptomatic patients had
moderate to severe exercise intolerance.
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ner as the grade of complexity of CHD advanced (Table 3).
3.5. Duration of postoperative ventilatory support, length of ICU
stay, and length of hospitalization
Two patients with complex ACHD who died shortly after the
operation were excluded from the analysis on these parame-
ters. The duration of postoperative ventilatory support was
not signiﬁcantly different among the groups (Table 4). The
length of ICU stay and length of hospitalization were signiﬁ-
cantly longer in complex CHD than in simple CHD (Table 4).
3.6. Mortality and morbidity
The 30-day mortality was 3.3% and the overall mortality was
5.4%. Forty-two complications, 23 of them major and 19 of
them minor, were detected in 33 patients (35.9%). The most
frequently observed complications were atrial tachyarrhythmia
(n= 9), respiratory failure requiring mechanical ventilatory
support (n= 6), low cardiac output requiring mechanical cir-
culatory support (ECMO or IABP; n= 4), and acute renal
failure requiring hemodialysis (n= 4). The complication rate
was signiﬁcantly higher in moderate or complex CHD than
in simple CHD (39.4% and 50.0% in moderate and complex
CHD, respectively, vs. 19.4% in simple CHD, p< 0.05).
3.7. Preoperative examinations
Eighteen cases underwent exercise tolerance testing, 5 by
CPET and 13 by 6MWT. In the CPET, exercise tolerance
was graded as follows based on the peak oxygen consumption
(VO2) or the slope of the regression line (VE/VCO2) between
minute ventilation (VE) and carbon dioxide production
(VCO2): normal (VO2 > 25 ml/kg/min, or VE/VCO2 < 30),
mild intolerance (20 < VO2 5 25 ml/kg/min, or 30 5 VE/
VCO2 < 40), moderate intolerance (15 < VO2 5 20 ml/kg/
min, or 40 5 VE/VCO2 < 50), or severe intolerance (VO2 515 ml/kg/min, or VE/VCO2 = 50). In the 6MWT, exercise tol-
erance was graded as follows based on the distance or
maximum decrease in oxygen saturation (SpO2): normal (dis-
tance = 600 m), mild intolerance (450 5 distance < 600 m),
moderate intolerance (300 5 distance < 450 m, or maximum
decrease of 5–10%), or severe intolerance (distance < 300 m,
or maximum decrease of = 10%). A remarkable discrepancy
was found between the patients’ subjective assessment (NYHA
class) and the severity of exercise intolerance by the CPET or
6MWT (Fig. 2). The NYHA class was 1 or 2 in all but one
of 13 patients with moderate-severe exercise intolerance and
a high mortality/major complication rate (53.8%), whereas
5 patients graded with normal or mild intolerance had a major
complication rate of 20.0% without any mortality.
Myocardial perfusion was evaluated in 18 cases. Myocar-
dial damage was detected in 8 patients with complex CHD
(Table 5A). Of these 8, 7 patients had either a history of cor-
onary transplantation or a pathophysiology of systemic right
ventricle (RV), tetralogy of Fallot (TOF), or single ventricle
(SV) (Table 5B). Four of the 8 patients with myocardial dam-
age had minor complications, but none died or suffered major
complications (Table 5B).
BNP was measured in 84 cases. NYHA class 3 patients had
signiﬁcantly higher BNP than NYHA class 1 or 2 patients
(Fig. 3). Patients with BNP equal to or greater than 100 had
a signiﬁcantly higher mortality/major complication rate than
patients with BNP less than 100, but the sensitivity (53.3%)
Table 5 Myocardial perfusion imaging: detection of myocar-
dial damage and the backgrounds of patients with myocardial
damage.
A. detection of damage
Complexity Myocardial damage
 +
Simple 2 0
Moderate 4 0
Complex 4 8
B. backgrounds of patients with myocardial damage
Case Age Operation Previous operation
or diagnosis
Mortality
Morbidity
1 19 AVR Post-Jatene No
2 21 PA angioplasty Post-Jatene No
3 23 TCPC conversion APC for TA No
4 26 TVR Post-Senning Minor
5 26 SAS resection Post-DSO Minor
6 32 TVR c-TGA No
7 34 TCPC conversion APC for SLV Minor
8 37 Re-Rastelli Post-Rastelli Minor
AVR, aortic valve replacement; PA, pulmonary artery; TCPC, total
cavo-pulmonary connection; APC, atrio-pulmonary connection;
TA, tricuspid atresia; TVR, tricuspid valve replacement; SAS,
subaortic stenosis; DSO, double switch operation; c-TGA, cor-
rected transposition of the great arteries; SLV, single left ventricle.
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too low to reliably identify patients at high risk of poor out-
come after cardiac surgery for ACHD (34.8% in patients with
BNP = 100 pg/ml vs. 11.5% in patients with BNP < 100 pg/
ml, p< 0.05).
Hb values were measured in all 92 cases. Hb was signiﬁ-
cantly greater in complex CHD than in simple or moderate
CHD (simple CHD 13.5 ± 1.9 g/dl, moderate CHD
13.8 ± 1.6 g/dl vs. complex CHD 15.9 ± 3.0 g/dl, p< 0.05).
The mortality/major complication rate did not signiﬁcantlyFigure 3 Distribution of preoperative BNP. BNP levels did not dif
CHD. NYHA class 3 patients had signiﬁcantly higher BNP than NY
deviation.differ among the groups graded as anemia (Hb < 13 g/dl,
8.0%), normocythemia (13 5 Hb< 18 g/dl, 20.7%), and poly-
cythemia (Hb = 18 g/dl, 42.9%).
GFR calculated in 68 cases did not differ among the three
groups. The mortality/major complication rate did not signif-
icantly differ among the groups graded as normal renal
function (GFR = 90 ml/min/1.73 m2, 22.6%), mildly impaired
renal function (60 5 GFR< 90 ml/min/1.73 m2, 13.3%), and
moderately impaired renal function (30 5 GFR< 60 ml/
min/1.73 m2, 16.7%).4. Discussion
4.1. Data on demographics
Age at the time of surgery at our institute was similar to those
in other reports from developed countries [4,9–11]. The rela-
tively early age distribution peak, in the patients’ twenties,
must be attributable to the improved survival rates after
surgery for complex defects. Most of the patients at the age
distribution peak required reoperations for sequelae or resi-
dues following corrective surgery they underwent in childhood.
In contrast, elderly patients primarily underwent closures for
atrial septal defects (ASDs) or other L–R shunt lesions de-
tected in adulthood.
The prevalence of reoperations, number of previous opera-
tions, and number of previous sternotomies have varied from
study to study [4,6,9,11,12]. More experienced institutes were
likely to treat patients who had undergone multiple previous
operations or sternotomies. About one-third of the patients
reported from the Mayo Clinic underwent three or more reo-
perations, and early mortality for reoperation rose to an extre-
mely high level in patients who had undergone ﬁve or more
sternotomies [13]. Only 11 of our patients (12% of all cases)
underwent three or more reoperations. None of our patients
received as many as ﬁve sternotomies, although 44.6% (41
cases) actually required re-sternotomy. Hence, our patients
underwent markedly fewer reoperations and re-sternotomies
than the patients at the Mayo Clinic.fer among the three groups classiﬁed based on the complexity of
HA class 1 or 2 patients. Data are shown as mean ± standard
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though operations for L–R shunt, valve operations, operations
for RVOT lesions, and Fontan revisions accounted for most
surgeries for ACHD at many institutes. The proportions of
these procedures were heterogeneously distributed, presum-
ably in accordance with the types of corrective surgeries
performed at each institute in the past. At our hospital, for
example, these same four procedures accounted for more than
90% of the ACHD operations, and the proportion of Fontan
revisions was especially high because of the many atrio-pul-
monary connections we had conducted a decade earlier. One
clinical feature speciﬁc to ACHD is a high proportion of oper-
ations for RVOT lesions. Srinathan et al. reported a dramatic
increase in the number of pulmonary valve replacements and
conduit replacements for RVOT lesions during 13 years of
observation [4].
Our ACHD patients could be divided into two major
groups: younger patients requiring reoperations following
corrective surgery for complex lesions and elderly patients
with simple CHD, most typically ASD. The younger pa-
tients typically underwent operations for valvular lesions
or RVOT lesions, or Fontan revisions, for moderate to com-
plex CHD.
4.2. Preoperative status
NYHA class 3 or 4 patients made up only about 10% in our
series, about half of the proportion reported from other devel-
oped countries (slightly higher than 20%) [9,11,13]. This differ-
ence helps our patients look relatively well-controlled before
the operations. Yet cardiologists widely recognize the clear dis-
crepancy between the NYHA class and severity of exercise
intolerance in ACHD patients. Diller et al. found that peak
oxygen consumption, one of the most reliable parameters for
evaluating exercise tolerance, was likely to be severely
depressed even in asymptomatic ACHD patients [14]. Our
exercise tolerance results on the small fraction of patients stud-
ied (18 cases) supported this discrepancy. The asymptomatic
patients with impaired exercise tolerance in our study also
tended to have a high mortality/major complication rate after
cardiac surgery. We thus concluded that NYHA class alone, a
subjective assessment by the patients themselves, was of rela-
tively little value for assessing the risk of cardiac surgery for
ACHD and was especially weak at identifying patients at high
risk of mortality or morbidity.
4.3. Amount of bleeding
Complex CHD or a history of previous median sternotomy
coincided with increased bleeding in our study. Yet all but 2
of our simple CHD patients underwent a ﬁrst median sternot-
omy, whereas all but 1 of our complex CHD patients had
undergone one or more sternotomies before. Hence, we were
unable to estimate the impacts of complex CHD and a history
of sternotomy on the amount of bleeding independently. In
terms of surgical procedures, most of the patients in the simple
CHD group underwent procedures that could be approached
via right atriotomy alone, while many patients with moderate
to complex CHD underwent procedures involving high-pres-
surized cardiac chambers or large vessels with longer CPB sup-
port. These differences must have also affected our results.4.4. CPB time, Ao-clamp time, and operation time
The CPB time, Ao-clamp time, and operation time in the three
groups in our series appeared to be the same or a bit longer
than those in other reports, when matched by the classiﬁcation
for ACHD complexity [4,12]. This supports the assessment
that our surgery was standard.
4.5. Duration of postoperative ventilatory support, length of ICU
stay, and length of hospitalization
The length of ICU stay and length of hospitalization in the
three groups tended to be longer than in the other reports,
when matched by the classiﬁcation for ACHD complexity
[4,9,12]. Most of the complex CHD patients who required
longer ICU stays and hospitalizations in our series underwent
TCPC conversion and had a extremely high mortality/major
complication rate. Hence, the higher proportion of TCPC
conversion in our series was a major contributing factor to
the longer ICU stays and hospitalizations in our study. Other
factors such as country differences in health insurance systems
might also have affected these parameters.
4.6. Mortality and morbidity
The overall mortality was clearly higher in our series than in
other reports or the database of the Society of Thoracic Sur-
geons in the United States, which reported mortality in the
range from 1.3% to 3.0% [6,9–13]. One series from the UK re-
ported a remarkably high mortality of 6.3% [4]. Yet when they
divided their 13-year study period into three equal time peri-
ods, the mortality in the last period was 3.4%, which was com-
parable to the rates in the other reports mentioned above [4].
Of the 5 cases who died in our study, 2 underwent TCPC con-
version, 1 underwent TCPC completion after bidirectional
Glenn operation, and 1 underwent grafting for aneurysmal
change in the ascending aorta after Fontan completion with
Damus–Kaye–Stansel anastomosis. Hence, the overall mortal-
ity in our study was increased by the high proportion of SV
physiology patients, a subgroup of patients who often died.
Unlike mortality, the morbidity in our series (35.9%) was
comparable with that in other reports (approximate range:
20–40%) [4,9,11,12].
4.7. Preoperative examinations
We found an obvious discrepancy between results of exercise
tolerance testing and NYHA class in our series. Even asymp-
tomatic or mildly symptomatic patients had moderate-severe
exercise intolerance. When Diller et al. monitored ACHD pa-
tients after exercise tolerance testing, they observed a stepwise
increase in mortality or hospitalization by grade of exercise
intolerance [14]. Their patients with severe exercise intolerance
had a rate of mortality and/or hospitalization of about 50%
after 3 years of follow-up, about triple the rate of their patients
with normal tolerance [14]. Although we evaluated exercise tol-
erance in only a small number of patients, 13 patients with
moderate-severe intolerance had a high mortality/major
complication rate (53.8%), whereas the other 5 patients with
normal tolerance or mild intolerance had a low complication
rate of 20.0% without mortality. The 6MWT was a less
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guidelines for the 6MWT from the American Thoracic Society
state that the results of the 6MWT should be considered a
complement to CPET, but not a replacement [16]. Some re-
ports, however, indicated the distance in 6MWT was corre-
lated with peak VO2 in CPET [17–19]. Our 13 cases with
moderate-severe exercise intolerance were free of orthopedic
disorders and had normal physical growth (excluding 1
short-stature female undergoing TCPC conversion), so we de-
ﬁned the severity of exercise intolerance simply by the walking
distance or decrease in SpO2 during the test, based on the re-
ported relationships between the distance and peak VO2
[18,19]. No deﬁnition for grading the severity of exercise intol-
erance by 6MWT has been established. Hence, our deﬁnition
for 6MWT grading might be suboptimal for evaluating exer-
cise tolerance objectively. Our results suggest that preoperative
exercise tolerance testing is useful for identifying patients at
high-risk of mortality or major complications. Exercise toler-
ance testing, especially objective testing by CPET, can thus
be recommended for risk assessment in cardiac surgery for
ACHD.
Perfusion mismatch can induce silent myocardial ischemia
and subsequent myocardial damage, which in turn can lead
to RV failure in the pathophysiologies of TOF, systemic RV,
or single RV. Myocardial perfusion has been evaluated in var-
ious types of ACHD [20–23]. These evaluations have covered
corrected transposition of the great arteries (TGA) [20] and
postoperative states after the Senning operation for TGA
[23], arterial switch operation for TGA [21], Ross operation
[21], and Fontan operation [22]. Myocardial perfusion was
maintained at or above the normal level at rest in every study
[20–23]. Yet the elevation of coronary perfusion after adeno-
sine administration fell short of the normal value in all of
the pathophysiologies studied [20–23]. Coronary reserve, that
is, the ratio of perfusion after adenosine infusion to perfusion
at rest, was smaller than normal as a consequence, even in the
pathophysiologies in which the perfusion at rest was greater
than normal [20–23]. There has been no direct evidence that
these characteristics in coronary perfusion cause silent myocar-
dial ischemia and subsequent myocardial damage. These ﬁnd-
ings are strongly suggestive, however, of at least a causal
relationship in these types of ACHD.
Of the 8 patients in whom myocardial damage was detected
preoperatively in our series, seven were consistent with one of
the abovementioned conditions. None of these 8 patients died
or developed major complications, so MPI alone was not use-
ful for identifying patients at high risk of poor outcome after
cardiac surgery for ACHD. We propose, however, that myo-
cardial perfusion should be evaluated in patients at high risk
of myocardial damage, speciﬁcally, in patients with TOF,
systemic RV, SV, or a history of coronary transplantation,
to detect the presence or extent of myocardial damage. Recog-
nition of the presence of myocardial damage can be helpful in
tailoring hemodynamic management through the selection of
cardiovascular-acting agents or strategies for myocardial
protection.
Bolger et al. demonstrated a signiﬁcant stepwise increase in
BNP with increasing NYHA class or with advancing ventricu-
lar dysfunction in ACHD patients [24]. BNP was elevated to
about 55 pmol/L in their patients of NYHA class 3 or 4, to
70 pmol/L in their patients with moderate ventricular
dysfunction, and to 250 pmol/L in their patients with severeventricular dysfunction [24]. Our study also demonstrated a
stepwise elevation of BNP with increasing NYHA class, and
the range of BNP in each class was very similar to that re-
ported by Bolger et al. Hsu and colleagues found perioperative
BNP to be predictive of mortality and morbidity after repair or
palliation surgery for CHD [25–27]. In our patients, preopera-
tive BNP alone was not highly predictive of mortality or major
complications. While our results demonstrate no utility of
preoperative BNP for detecting the presence of ventricular dys-
function or myocardial damage, they do suggest that preoper-
ative BNP is a potentially valuable predictor of poor outcome
after cardiac surgery in ACHD.
In a report from Dimopoulos et al., anemic ACHD patients
(Hb < 13 g/dl) had threefold higher mortality than non-ane-
mic ACHD patients during a median follow-up of 47 months
at a tertiary center [28]. Dimopoulos’ group also found, by
as early as the ﬁrst year of a 4.1-year (median) follow-up of
ACHD, that patients with moderate or greater renal dysfunc-
tion (GFR< 60 ml/min/1.73 m2) had ﬁvefold mortality, and
patients with mild renal dysfunction (60 5 GFR< 90 ml/
min/1.73 m2) had signiﬁcantly higher mortality, compared
with patients with normal renal function (GFR = 90 ml/min/
1.73 m2) [29]. Neither anemia nor renal dysfunction affected
the mortality/major complication rate after cardiac surgery
in the present study. While we believe these factors to be less
predictive of poor outcomes after cardiac surgery, more data
from a larger number of patients will be necessary to conﬁrm
this.
Our study is subject to several limitations. Anesthesiologists
must closely consider the measures used to assess the risk of
intraoperative hemodynamic instability preoperatively. Here,
however, we made no attempt to evaluate intraoperative
hemodynamic instability, although we did assess the usefulness
of preoperative examinations for predicting the outcomes after
cardiac surgery for ACHD. In addition, exercise tolerance test-
ing or MPI was performed in a small population of patients
with a high frequency of complex ACHD to elucidate the
predictive values of these examinations in detecting patients
at high risk of poor outcomes. We await further studies with
larger numbers of patients, with more widely varying patho-
physiologies, from simple to complex ACHD lesions, and with
assessments of intraoperative hemodynamic instability in
addition to outcomes after cardiac surgery.
In conclusion, this retrospective review demonstrated that
cardiac surgery could be safely performed in most ACHD
cases. In ACHD with severe complexity, especially SV physiol-
ogy, however, the risks of bleeding, mortality, and morbidity
were markedly increased and the ICU stay and hospitalization
were markedly prolonged. A single preoperative examination
reliable in predicting poor outcome after cardiac surgery for
ACHD has yet to be established. Exercise tolerance testing
may be one of the most useful examinations for identifying
patients at high risk of mortality or major complications.
MPI should be applied to patients with high-risk pathophysi-
ologies of abnormal coronary perfusion, in order to detect
the presence and extent of myocardial damage. BNP can also
be valuable in predicting poor outcomes after cardiac surgery.Research support
None.
210 S. Kurokawa et al.Conﬂict of interest
None.
References
[1] Shiina Y, Toyoda T, Kawagoe Y, Tateno S, Shirai T, Wakisaka
Y, Matsuo K, Mizuno Y, Terai M, Hamada H, Niwa K.
Prevalence of adult patients with congenital heart disease in
Japan. Int J Cardiol 2011;146:13–6.
[2] Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L,
Hoffman JI, Somerville J, Williams RG, Webb GD. Task force
1: the changing proﬁle of congenital heart disease in adult life. J
Am Col Cardiol 2001;37:1170–5.
[3] Marelli AJ, Therrien J, Mackie AS, Ionescu-Ittu R, Pilote L.
Planning the specialized care of adult congenital heart disease
patients: from numbers to guidelines; an epidemiologic
approach. Am Heart J 2009;157:1–8.
[4] Srinathan SK, Bonser RS, Sethia B, Thorne SA, Brawn WJ,
Barron DJ. Changing practice of cardiac surgery in adult
patients with congenital heart disease. Heart 2004;91:207–12.
[5] Bedard E, Shore DF, Gatzoulis MA. Adult congenital heart
disease: a 2008 overview. Br Med Bull 2008;85:151–80.
[6] Niwa K, Perloff JK, Webb GD, Murphy D, Liberthson R,
Warnes CA, Gatzoulis MA. Survey of specialized tertiary care
facilities for adults with congenital heart disease. Int J Cardiol
2004;96:211–6.
[7] Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L.
Congenital heart disease in the general population; changing
prevalence and age distribution. Circulation 2007;115:163–72.
[8] Toyoda T, Tateno S, Kawasoe Y, Shirai T, Shiina Y, Matsuo K,
Niwa K. Nationwide survey of care facilities for adults with
congenital heart disease in Japan. Circ J 2009;73:1147–50.
[9] Vida VL, Berggren H, Brawn WJ, Daenen W, Di Carlo D, Di
Donato R, Lindberg HL, Corno AF, Fragata J, Elliott MJ,
Hraska V, Kiraly L, Lacour-Gayet F, Maruszewski B, Rubay J,
Sairanen H, Sarris G, Urban A, Van Doorn C, Ziemer G, Stellin
G. Risk of surgery for congenital heart disease in the adult: a
multicentered European study. Ann Thorac Surg 2007;83:161–8.
[10] Mahle WT, Kirshbom PM, Kanter KR, Kogon BM. Cardiac
surgery in adults performed at children’s hospitals: trends and
outcomes. J Thorac Cardiovasc Surg 2008;136:307–11.
[11] Putman LM, van GamerenM, Meijboom FJ, de Jong PL, Roos-
Hesselink JW, Witsenburg M, Takkenberg JJM, Bogers AJJC.
Seventeen years of adult congenital heart surgery: a single centre
experience. Eur J Cardiothorac Surg 2009;36:96–104.
[12] Gnanappa GK, Ganigara M, Prabhu A, Varma SK, Murmu U,
Varghese R, Valliatu J, Kumar RNS. Outcome of complex adult
congenital heart surgery in the developing world. Congenit
Heart Dis 2011;6:2–8.
[13] Dearani JA, Connolly HM, Martinez R, Fontanet H, Webb
GD. Caring for adults with congenital cardiac disease: successes
and challenges for 2007 and beyond. Cardiol Young
2007;17(Suppl. 2):87–96.
[14] Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan
SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-
Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in
adult congenital heart disease: comparative severity, correlates,
and prognostic implication. Circulation 2005;112:828–35.
[15] Dimopoulos K, Diller GP, Piepoli MF, Gatzoulis MA. Exercise
intolerance in adults with congenital heart disease. Cardiol Clin
2006;24:641–60.[16] ATS statement: guidelines for the six-minute walk test. Am J
respire Crit Care Med 2002;166:111–7.
[17] Oudiz RJ, Barst RJ, Hansen JE, Sun XG, Garofano R, Wu X,
Wasserman K. Cardiopulmonary exercise testing and six-minute
walk correlations in pulmonary arterial hypertension. Am J
Cardiol 2006;997:123–6.
[18] Niedeggen A, Skobel E, Haager P, Lepper W, Muhler E, Franke
A. Comparison of the 6-minute walk test with established
parameters for assessment of cardiopulmonary capacity in
adults with complex congenital cardiac disease. Cardiol Young
2005;15:385–90.
[19] Chuang ML, Lin LF, Wasserman K. The body weight-walking
distance product as related to lung function, anaerobic threshold
and peak VO2 in COPD patients. Respir Med 2001;95:618–26.
[20] Hauser M, Bengel FM, Hager A, Kuehn A, Nekolla SG,
Kaemmerer H, Schwaiger M, Hess J. Impaired myocardial
blood ﬂow and coronary ﬂow reserve of the anatomical right
systemic ventricle in patients with congenitally corrected
transposition of the great arteries. Heart 2003;89:1231–5.
[21] Hauser M, Bengel FM, Kuehn A, Sauer U, Zylla S, Braun SL,
Nekolla SG, Obenhoffer R, Lange R, Schwaiger M, Hess J.
Myocardial blood ﬂow and ﬂow reserve after coronary
reimplantation in patients after arterial switch and Ross
operation. Circulation 2001;103:1875–80.
[22] Hauser M, Bengel FM, Kuehn A, Sauer U, Nekolla SG, Eicken
A, Schwaiger M, Hess J. Myocardial perfusion and coronary
ﬂow reserve assessed by positron emission tomography in
patients after Fontan-like operations. Pediatr Cardiol
2003;24:386–92.
[23] Fratz S, Hauser M, Bengel FM, Hager A, Kaemmerer H,
Schwaiger M, Hess J, Stern HC. Myocardial scars determined
by delayed-enhancement magnetic resonance imaging and
positron emission tomography are not common in right
ventricles with systemic function in long-term follow up. Heart
2006;92:1673–7.
[24] Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M,
Coats AJS, Anker SD, Gatzoulis MA. Neurohormonal
activation and the chronic heart failure syndrome in adults
with congenital heart disease. Circulation 2002;106:92–9.
[25] Hsu JH, Keller RL, Chikovani O, Cheng H, Hollander SA, Karl
TR, Azakie A, Adatia I, Oishi P, Fineman JR. B-type natriuretic
peptide levels predict outcome after neonatal cardiac surgery. J
Thorac Cardiovasc Surg 2007;134:939–45.
[26] Hsu JH, Oishi PE, Keller RL, Chikovani O, Karl TR, Azalie A,
Adatia I, Fineman JR. Perioperative B-type natriuretic peptide
levels predict outcome after bidirectional cavopulmonary
anastomosis and total cavopulmonary connection. J Thorac
Cardiovasc Surg 2008;135:746–53.
[27] Chikovani O, Hsu JH, Keller R, Karl TR, Azakie A, Adatia I,
Oishi P, Fineman JR. B-type natriuretic peptide levels predict
outcomes for children on extracorporeal life support after
cardiac surgery. J Thorac Cardiovasc Surg 2007;134:1179–87.
[28] Dimopoulos K, Diller GP, Giannakoulas G, Petraco R,
Chamaidi A, Karaoli E, Mullen M, Swan L, Piepoli MF,
Poole-Wilson PA, Francis DP, Gatzoulis MA. Anemia in adults
with congenital heart disease relates to adverse outcome. J Am
Col Cardiol 2009;54:2093–100.
[29] Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A,
Papadopoulou SA, Babu-Narayan SV, Salukhe TV, Piepoli
MF, Poole-Wilson PA, Best N, Francis DP, Gatzoulis MA.
Prevalence, predictors, and prognostic value of renal
dysfunction in adults with congenital heart disease. Circulation
2008;117:2320–8.
